Status:
COMPLETED
Effects of Low-Level Laser Therapy on Oxidative Stress Levels
Lead Sponsor:
Istanbul Medipol University Hospital
Conditions:
Hashimoto Thyroiditis
Autoimmune Thyroiditis
Eligibility:
All Genders
18-65 years
Phase:
NA
Brief Summary
Hashimoto's thyroiditis (HT) is the most commonly observed inflammatory and autoimmune disease of the thyroid gland. Recent evidence has suggested that low-level laser therapy (LLLT) can improve thyro...
Detailed Description
Hashimoto's thyroiditis (HT) is the most commonly observed inflammatory and autoimmune disease of the thyroid gland. HT is the main cause of spontaneous hypothyroidism in adults. Symptoms of hypothyro...
Eligibility Criteria
Inclusion
- Cases between the ages of 18-65 who applied to the Kosuyolu Istanbul Medipol Hospital Endocrinology and Metabolic Diseases Clinic between 2020-2021 and diagnosed as "Hashimoto Thyroiditis" by a specialist physician will be included in the study.
Exclusion
- Acute infection
- Use of immunosuppressants, immunostimulants and drugs that interfere with the production, transport, and metabolism of thyroid hormones
- Thyroid nodules
- Tracheal stenosis
- Serious illness
- History of exposure to ionizing radiation and/or neoplasia in the cervical region
- Malignancy and a history of thyroid surgery
- Hypothyrodism caused by postpartum thyroiditis
- Pregnancy and breastfeeding period
- Identification and diagnosis of the cases with neurological and psychiatric disorders.
Key Trial Info
Start Date :
February 9 2021
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
June 30 2022
Estimated Enrollment :
46 Patients enrolled
Trial Details
Trial ID
NCT04754607
Start Date
February 9 2021
End Date
June 30 2022
Last Update
December 13 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Sümeyye TUNÇ
Istanbul, Turkey (Türkiye)